Your browser doesn't support javascript.
loading
Potential Interplay between Dietary Saturated Fats and Genetic Variants of the NLRP3 Inflammasome to Modulate Insulin Resistance and Diabetes Risk: Insights from a Meta-Analysis of 19 005 Individuals.
Murphy, Aoife M; Smith, Caren E; Murphy, Leanne M; Follis, Jack L; Tanaka, Toshiko; Richardson, Kris; Noordam, Raymond; Lemaitre, Rozenn N; Kähönen, Mika; Dupuis, Josée; Voortman, Trudy; Marouli, Eirini; Mook-Kanamori, Dennis O; Raitakari, Olli T; Hong, Jaeyoung; Dehghan, Abbas; Dedoussis, George; de Mutsert, Renée; Lehtimäki, Terho; Liu, Ching-Ti; Rivadeneira, Fernando; Deloukas, Panagiotis; Mikkilä, Vera; Meigs, James B; Uitterlinden, Andre; Ikram, Mohammad A; Franco, Oscar H; Hughes, Maria; O' Gaora, Peadar; Ordovás, José M; Roche, Helen M.
Afiliação
  • Murphy AM; Nutrigenomics Research Group, Conway Institute of Biomedical and Biomolecular Sciences, University College Dublin, Belfield, Dublin 4, D04 V1W8, Ireland.
  • Smith CE; Jean Mayer USDA Human Nutrition Research Centre on Aging, Tufts University, Boston, MA, 02111, USA.
  • Murphy LM; UCD School of Biomolecular and Biomedical Science, Conway Institute of Biomedical and Biomolecular Sciences, University College Dublin, Belfield, Dublin 4, D04 V1W8, Ireland.
  • Follis JL; Department of Mathematics, University of St. Thomas, Houston, TX, 77006-4626, USA.
  • Tanaka T; Translational Gerontology Branch, National Institute on Aging, Baltimore, MD, 21224, USA.
  • Richardson K; Jean Mayer USDA Human Nutrition Research Centre on Aging, Tufts University, Boston, MA, 02111, USA.
  • Noordam R; Department of Internal Medicine, Section of Gerontology and Geriatrics, Leiden University Medical Center, Leiden, 2333 ZA., The Netherlands.
  • Lemaitre RN; Department of Medicine, University of Washington, Seattle, WA, 98195, USA.
  • Kähönen M; Department of Clinical Physiology, Tampere University Hospital and University of Tampere School of Medicine, 33521, Tampere, Finland.
  • Dupuis J; Department of Biostatistics, Boston University School of Public Health, Boston, MA, 02130, USA.
  • Voortman T; Department of Epidemiology, Erasmus MC-University Medical Center, Postbus 2040, 3000 CA, Rotterdam, The Netherlands.
  • Marouli E; William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, E1 4NS, UK.
  • Mook-Kanamori DO; Department of Clinical Epidemiology and Department of Public Health and Primary Care, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands.
  • Raitakari OT; Department of Clinical Physiology and Nuclear Medicine, Turku University Hospital, and Research Centre of Applied and Preventive Cardiovascular Medicine, University of Turku, 20521, Turku, Finland.
  • Hong J; Department of Biostatistics, Boston University School of Public Health, Boston, MA, 02130, USA.
  • Dehghan A; Department of Epidemiology, Erasmus MC-University Medical Center, Postbus 2040, 3000 CA, Rotterdam, The Netherlands.
  • Dedoussis G; Department of Nutrition and Dietetics, School of Health Science and Education, Harokopio University, El. Venizelou 70, 17671, Athens, Greece.
  • de Mutsert R; Department of Clinical Epidemiology and Department of Public Health and Primary Care, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands.
  • Lehtimäki T; Department of Clinical Chemistry, Fimlab Laboratories and Finnish Cardiovascular Research Center-Tampere, Faculty of Medicine and Life Sciences, University of Tampere, Tampere, 33520, Finland.
  • Liu CT; Department of Biostatistics, Boston University School of Public Health, Boston, MA, 02130, USA.
  • Rivadeneira F; Department of Internal Medicine, Erasmus University Medical Center, Postbus 2040, 3000 CA, Rotterdam, The Netherlands.
  • Deloukas P; William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, E1 4NS, UK.
  • Mikkilä V; Division of Nutrition, Department of Food and Environmental Sciences, 00014, Helsinki, Finland.
  • Meigs JB; Division of General Internal Medicine, Massachusetts General Hospital, Boston, MA, 02114, USA.
  • Uitterlinden A; Harvard Medical School, Boston, MA, 02115, USA.
  • Ikram MA; Broad Institute, Cambridge, MA, 02142, USA.
  • Franco OH; Department of Internal Medicine, Erasmus University Medical Center, Postbus 2040, 3000 CA, Rotterdam, The Netherlands.
  • Hughes M; Department of Epidemiology, Erasmus MC-University Medical Center, Postbus 2040, 3000 CA, Rotterdam, The Netherlands.
  • O' Gaora P; Department of Epidemiology, Erasmus MC-University Medical Center, Postbus 2040, 3000 CA, Rotterdam, The Netherlands.
  • Ordovás JM; Nutrigenomics Research Group, Conway Institute of Biomedical and Biomolecular Sciences, University College Dublin, Belfield, Dublin 4, D04 V1W8, Ireland.
  • Roche HM; UCD School of Biomolecular and Biomedical Science, Conway Institute of Biomedical and Biomolecular Sciences, University College Dublin, Belfield, Dublin 4, D04 V1W8, Ireland.
Mol Nutr Food Res ; 63(22): e1900226, 2019 11.
Article em En | MEDLINE | ID: mdl-31432628
ABSTRACT
SCOPE Insulin resistance (IR) and inflammation are hallmarks of type 2 diabetes (T2D). The nod-like receptor pyrin domain containing-3 (NLRP3) inflammasome is a metabolic sensor activated by saturated fatty acids (SFA) initiating IL-1ß inflammation and IR. Interactions between SFA intake and NLRP3-related genetic variants may alter T2D risk factors.

METHODS:

Meta-analyses of six Cohorts for Heart and Aging Research in Genomic Epidemiology Consortium (n = 19 005) tested interactions between SFA and NLRP3-related single-nucleotide polymorphisms (SNPs) and modulation of fasting insulin, fasting glucose, and homeostasis model assessment of insulin resistance.

RESULTS:

SFA interacted with rs12143966, wherein each 1% increase in SFA intake increased insulin by 0.0063 IU mL-1 (SE ± 0.002, p = 0.001) per each major (G) allele copy. rs4925663, interacted with SFA (ß ± SE = -0.0058 ± 0.002, p = 0.004) to increase insulin by 0.0058 IU mL-1 , per additional copy of the major (C) allele. Both associations are close to the significance threshold (p < 0.0001). rs4925663 causes a missense mutation affecting NLRP3 expression.

CONCLUSION:

Two NLRP3-related SNPs showed potential interaction with SFA to modulate fasting insulin. Greater dietary SFA intake accentuates T2D risk, which, subject to functional validation, may be further elaborated depending on NLRP3-related genetic variants.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Resistência à Insulina / Gorduras na Dieta / Polimorfismo de Nucleotídeo Único / Diabetes Mellitus Tipo 2 / Inflamassomos / Proteína 3 que Contém Domínio de Pirina da Família NLR Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Revista: Mol Nutr Food Res Assunto da revista: CIENCIAS DA NUTRICAO Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Irlanda

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Resistência à Insulina / Gorduras na Dieta / Polimorfismo de Nucleotídeo Único / Diabetes Mellitus Tipo 2 / Inflamassomos / Proteína 3 que Contém Domínio de Pirina da Família NLR Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Revista: Mol Nutr Food Res Assunto da revista: CIENCIAS DA NUTRICAO Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Irlanda